| Title | Clinical Lymphoma, Myeloma and Leukemia |
| Abbreviation | Clin. Lymphoma Myeloma Leuk. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q3); Hematology (Q3); Oncology (Q3) |
| h-index | 65 |
| Overall Rank/Ranking | 9872 |
| SCImago Journal Rank (SJR) | 0.548 |
| Impact Score | 1.13 |
| Publisher | Elsevier Inc. |
| Country | United States |
| ISSN | 21522650, 21522669 |
| Best Quartile | Q3 |
| Coverage History | 2010-2023 |
Clinical Lymphoma, Myeloma and Leukemia is a journal covering the technologies/fields/categories related to Cancer Research (Q3); Hematology (Q3); Oncology (Q3). It is published by Elsevier Inc.. The overall rank of Clinical Lymphoma, Myeloma and Leukemia is 9872. According to SCImago Journal Rank (SJR), this journal is ranked 0.548. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 65. The best quartile for this journal is Q3.
The ISSN of Clinical Lymphoma, Myeloma and Leukemia journal is 21522650, 21522669. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Lymphoma, Myeloma and Leukemia is cited by a total of 1737 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Clinical Lymphoma, Myeloma and Leukemia is 1.13, which is computed in 2024 as per its definition. Clinical Lymphoma, Myeloma and Leukemia IF is decreased by a factor of 0.89 and approximate percentage change is -44.06% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Clinical Lymphoma, Myeloma and Leukemia is 1.13. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.13 |
| 2022 | 2.02 |
| 2021 | 2.10 |
| 2020 | 2.36 |
| 2019 | 2.14 |
| 2018 | 2.10 |
| 2017 | 2.14 |
| 2016 | 1.90 |
| 2015 | 2.01 |
| 2014 | 1.89 |
Clinical Lymphoma, Myeloma and Leukemia has an h-index of 65. It means 65 articles of this journal have more than 65 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Lymphoma, Myeloma and Leukemia is 21522650, 21522669. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Lymphoma, Myeloma and Leukemia is 9872. According to SCImago Journal Rank (SJR), this journal is ranked 0.548. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.548 |
| 2022 | 0.758 |
| 2021 | 0.778 |
| 2020 | 0.940 |
| 2019 | 0.819 |
| 2018 | 1.059 |
| 2017 | 0.895 |
| 2016 | 0.772 |
| 2015 | 0.879 |
| 2014 | 0.820 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 9872 |
| 2022 | 6434 |
| 2021 | 5955 |
| 2020 | 4787 |
| 2019 | 5750 |
| 2018 | 4001 |
| 2017 | 5075 |
| 2016 | 6046 |
| 2015 | 5250 |
| 2014 | 5554 |
Clinical Lymphoma, Myeloma and Leukemia is published by Elsevier Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2010-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Lymphoma, Myeloma and Leukemia is Clin. Lymphoma Myeloma Leuk.. This abbreviation ('Clin. Lymphoma Myeloma Leuk.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q3); Hematology (Q3); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Lymphoma, Myeloma and Leukemia latest impact IF is 1.13. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.36 (2020) and 1.13 (2023), respectively, in the last 10 years. Moreover, its average IS is 1.98 in the previous 10 years.
The Clinical Lymphoma, Myeloma and Leukemia has an SJR (SCImago Journal Rank) of 0.548, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.059 in 2018 and the lowest being 0.548 in 2023. Furthermore, the average SJR of the Clinical Lymphoma, Myeloma and Leukemia over the previous 10-year period stands at 1.98.
The latest h-index of the Clinical Lymphoma, Myeloma and Leukemia is 65.
The Clinical Lymphoma, Myeloma and Leukemia is published by the Elsevier Inc., with its country of publication being the United States.
The Clinical Lymphoma, Myeloma and Leukemia is currently ranked 9872 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4001 in 2018 and its lowest position of 9872 in 2023.
The standard ISO4 abbreviation for the Clinical Lymphoma, Myeloma and Leukemia is Clin. Lymphoma Myeloma Leuk..
Clinical Lymphoma, Myeloma and Leukemia is classified as a journal that the Elsevier Inc. publishes.
The Clinical Lymphoma, Myeloma and Leukemia encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Lymphoma, Myeloma and Leukemia is assigned the following International Standard Serial Numbers (ISSN): 21522650, 21522669.
The best quartile for the Clinical Lymphoma, Myeloma and Leukemia is Q3 (2023).
The Clinical Lymphoma, Myeloma and Leukemia coverage history can be summarized as follows: 2010-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Indian Phytopathology | journal | 15501 | Springer Nature | 16 | 1.09 |
| Museum Management and Curatorship | journal | 10406 | Routledge | 40 | 1.72 |
| Proteomics - Clinical Applications | journal | 9438 | Wiley-VCH Verlag | 64 | 2.28 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Proceedings of the Royal Society of Queensland | journal | 21886 | Royal Society of Queensland | 12 | 0.00 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 1.13 |
| 2022 | 2.02 |
| 2021 | 2.10 |
| 2020 | 2.36 |
| 2019 | 2.14 |
| 2018 | 2.10 |
| 2017 | 2.14 |
| 2016 | 1.90 |
| 2015 | 2.01 |
| 2014 | 1.89 |
